Calorie restriction lowers C3, an immune protein tied to aging and inflammation, improving health without requiring weight ...
Novartis Pharmaceuticals Canada Inc. ("Novartis Canada") announced today that Health Canada has granted a Notice of Compliance (NOC) for Fabhalta® (iptacopan capsules) for the treatment of adult ...
Morning Overview on MSN
Scientists may have found a way to slow Parkinson’s by strengthening the brain’s own protective systems instead of just treating symptoms
Every drug approved for Parkinson’s disease does the same thing: it manages symptoms. None slows the underlying destruction ...
Myokines are hormones that communicate via the bloodstream with various organs such as the brain, adipose tissue, liver, bone ...
Ocular infections and related inflammatory disorders are important causes of visual morbidity worldwide and may arise from viral, bacterial, fungal, and ...
Researchers are testing new therapies to treat celiac disease beyond a gluten-free diet, including immune tolerance drugs and ...
Good morning, and welcome to Ocugen First Quarter 2026 Financial Results and Business Update. [Operator Instructions] I will now turn the call over to Tiffany Hamilton, Ocugen's Head of Corporate ...
One-Year Cohort 1 Data and Initial Cohort 2 Data from RIDGE™-1 Phase 1b/2 Trial of TN-401 for PKP2-Associated ARVC to be Presented at ASGCT ...
Study reveals a new anti-aging approach that improves muscle function by activating fat−brain−muscle communication triggered ...
SYNC Metabolism Support Formula+ includes the following product details, ingredient information, and usage guidance for ...
A pilot trial is enrolling patients to test whether vagus nerve stimulation can safely promote remyelination in adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results